.[J] Chinese Pharmaceutical Journal, 2011,V46(12): 963-965
��
[1]
ZHANG Y W. Selection of national essential drugs and pharmacoeconomics [J]. Chin Health Econ(�й��������ã�2009 ��28��2��80-81. [2] MENG R. Investigation on the selection of essential drug list in China [J]. J Chin Pharm (�й�ҩ����2010�� 24��2211-2213. [3] ANIZA M H�� OTGONBAYAR R�� MUNKHTUUL Y. Importance of economic evaluation in health care decision making[J]. J Commun Health��2008�� 14( 1��1-10. [4] LI H T. To Discuss the Application of the evaluation of pharmacoeconomics in guiding clinical rational use of drug[J]. Chin Hosp Man (�й�ҽԺ���� 2007��27��3��45-47. [5] LI Y P. National essential drugs list and drug related problems of economics[J]. Chin Lic Pharm (�й�ִҵҩʦ�� 2009�� 6 ��2��30-32/[6] TORRANCE G W. Canadian guidelines for economic evaluation of pharmaceuticals. Canadian Collaborative Workshop for Pharmacoeconomics[J]. Pharmacoeconomics�� 1996��9(6��535-559. [7] GENG X N. An analysis of evidence-based pharmaceutical economic evaluation[J]. Chin J Pharm Econ (�й�ҩ�ﾭ��ѧ��־��2010��4��40-45. [8] EFRON B. Bootsrap methods�� another look at the jackknife[J]. Annu Stat�� 1979�� 7(1��1-26. [9] EFRON B. Bootstrap confidence intervals�� Good or bad [J]. Psych Bull�� 1988��104��2��293-296.
2011, Vol. 46 